CPT code 30905 denotes the initial procedural control of posterior nasal bleeding by any method. Nationally, this code is used to report the first definitive intervention for posterior epistaxis, an acute condition that often requires urgent management and can involve emergency, inpatient, or procedural-suite care. Accurate use of this code affects clinical documentation, facility classification of service, and payer adjudication for acute ENT procedures.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find practical information on the clinical context of posterior epistaxis interventions, common sites of service where the code is reported, and the role of initial-control coding in claims workflows. The publication outlines benchmark considerations, typical billing scenarios, and areas where policy updates or payer-specific rules may affect reimbursement and claims processing.

This summary serves clinicians, coding professionals, and health policy analysts seeking a concise national overview of CPT code 30905, including how it maps to acute ENT procedural care and where further payer-specific guidance should be consulted. Data not available in the input is noted where applicable.